Costs Associated with Symptomatic Systolic Heart Failure
- 1 January 1999
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 16 (4), 399-407
- https://doi.org/10.2165/00019053-199916040-00007
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Physician Management of Patients With Heart Failure and Normal Versus Decreased Left Ventricular Systolic FunctionThe American Journal of Cardiology, 1998
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban populationThe Lancet, 1997
- An Economic Analysis of the Survival and Ventricular Enlargement (SAVE) StudyPharmacoEconomics, 1997
- Assessing diagnosis in heart failure: which features are any use?QJM: An International Journal of Medicine, 1997
- The Pharmacoeconomics of ACE Inhibitors in Chronic Heart FailurePharmacoEconomics, 1996
- Heart FailurePharmacoEconomics, 1996
- Effects of ACE Inhibitors on Heart Failure in The NetherlandsPharmacoEconomics, 1993
- Clinical characteristics of patients in Studies of Left Ventricular Dysfunction (SOLVD)The American Journal of Cardiology, 1992
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987